Table 2. Combinations in Uniform Design and their lipid droplet reduction rate (mean ± s.d.).
| GROUP | CG-4 | CG-10 | CG-14 | LDs (%) |
|---|---|---|---|---|
| 1 | 1 | 3 | 2 | 24.95 ± 3.17 |
| 2 | 2 | 1 | 3 | 27.18 ± 5.60 |
| 3 | 2 | 2 | 2 | 31.05 ± 5.34 |
| 4 | 3 | 1 | 2 | 23.44 ± 3.74 |
| 5 | 1 | 2 | 3 | 16.92 ± 3.48 |
| 6 | 2 | 3 | 1 | 19.85 ± 2.23 |
| 7 | 3 | 2 | 1 | 17.61 ± 3.88 |
| 8 | 4 | 1 | 1 | 15.72 ± 4.77 |
| 9 | 6 | 0 | 0 | 14.00 ± 5.92 |
| 10 | 0 | 6 | 0 | 13.63 ± 5.33 |
| 11 | 0 | 0 | 6 | 9.30 ± 5.03 |
Lipid droplet content was measured by the flow cytometer method, as mentioned above, and the data were transformed into a reduction rate (%) compared with FFA treatment model group.